Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

[Malignant solitary fibrous tumors: a clinicopathological and molecular genetic analysis].

Authors:
Y P Huang W W Wang P Li X Y Zhao B B Wang G Z Jiang W C Li Z H Zhao

Zhonghua Bing Li Xue Za Zhi 2022 Jun;51(6):518-523

Department of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

To explore the clinicopathological features, immunophenotype and molecular genetic characteristics of malignant solitary fibrous tumor (MSFT). Seven cases of MSFT were collected from the First Affiliated Hospital of Zhengzhou University from July 2018 to December 2020. Immunohistochemistry, RNA-based NGS and DNA-based NGS were performed. s Among the 7 patients, there were 5 males and 2 females with a median age of 53 years (37-69 years). Two tumors located at skull base, and one in the tentorium of cerebellum, parietal occipital region, occipital area, chest and buttock respectively. The maximum diameter of the tumor was 2.5-20.0 cm. Microscopically, typical hemangiopericomatoid structures were noted; the tumor was cellular, fusiform or oval, very pleomorphic, with necrosis and high mitotic figures (>4/10 HPF). In some cases, classical solitary fibrous tumor morphology and dedifferentiated region were observed. Immunohistochemically, the tumor was positive for CD34 (6/7), STAT6 (7/7), bcl-2 (7/7), but negative for S-100 (7/7); CKpan or EMA was positive to varying degrees; mutated p53 was noted (3/7); Ki-67 positive index was more than 10%. NAB2-STAT6 gene fusion was typically detected in all the 7 cases. In 4 cases, ZNF415-FGFR1, COPG1-MET, IPO11-LRRC70_ncRNA-PLAG1 and Clorf198-CD274 (PD-L1) gene fusions were also detected. NOTCH1 mutation was found in 7 cases and TP53 mutation in 4 cases. TERT promoter mutations were not detected in all the cases. MSFT is rare and needs to be differentiated from many other spindle cell tumors. Especially when tumors express epithelial markers, they are easily misdiagnosed as sarcomatoid carcinoma and synovial sarcoma, etc. Immunohistochemistry and molecular detection of NAB2-STAT6 gene fusion have important diagnostic values. NOTCH1 and TP53 mutations may be associated with the progression of MSFT. Some patients have FGFR1 gene fusion and MET gene fusion, which may be potential therapeutic targets.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn112151-20210910-00664DOI Listing
June 2022

Publication Analysis

Top Keywords

gene fusion
16
solitary fibrous
12
nab2-stat6 gene
8
detected cases
8
molecular genetic
8
mutation cases
8
fibrous tumor
8
cases msft
8
cases
7
tumor
5
gene
5
high mitotic
4
tumors express
4
tumors tumors
4
necrosis high
4
figures >4/10
4
mitotic figures
4
therapeutic targets
4
cell tumors
4
hpf cases
4

Keyword Occurance

Similar Publications

JIB-04, a histone demethylase Jumonji C domain inhibitor, regulates phenotypic switching of vascular smooth muscle cells.

Authors:
Yi He Xin Yi Zihao Zhang Hanshen Luo Rui Li Xin Feng Ze-Min Fang Xue-Hai Zhu Wenlin Cheng Ding-Sheng Jiang Fang Zhao Xiang Wei

Clin Epigenetics 2022 Aug 13;14(1):101. Epub 2022 Aug 13.

Division of Cardiothoracic and Vascular Surgery, Sino-Swiss Heart-Lung Transplantation Institute, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Ave, Wuhan, 430030, Hubei, China.

Background: Vascular smooth muscle cell (VSMC) phenotype switching is critical for neointima formation, which is the major cause of restenosis after stenting or coronary artery bypass grafting. However, the epigenetic mechanisms regulating phenotype switching of VSMCs, especially histone methylation, are not well understood. As a main component of histone lysine demethylases, Jumonji demethylases might be involved in VSMC phenotype switching and neointima formation. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).

Authors:
Guillaume Gricourt Violaine Tran-Quang Jean-Michel Cayuela Elisa Boudali Sihem Tarfi Quentin Barathon Romain Daveau Corine Joy Orianne Wagner-Ballon Dominique Bories Cécile Pautas Sébastien Maury Delphine Rea Lydia Roy Ivan Sloma

J Mol Diagn 2022 Aug 10. Epub 2022 Aug 10.

AP-HP, Henri Mondor University Hospital, Hematology and Immunology Department, F-94010 Creteil, France; Univ Paris Est Creteil, INSERM, IMRB, F-94010 Creteil, France. Electronic address:

Several fusion genes such as BCR::ABL1, FIP1L1::PDGFRA and PML::RARA are now efficiently targeted by specific therapies in leukemic patients. Although these therapies have significantly improved patient outcomes, leukemia relapse and progression remain a clinical concern. Most myeloid next-generation sequencing (NGS) panels don't detect or quantify these fusions. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Age-restricted functional and developmental differences of neonatal platelets.

Authors:
Zhaoyan Liu Cecilia Avila Lisa E Malone Dmitri V Gnatenko Jawaad Sheriff Wei Zhu Wadie F Bahou

J Thromb Haemost 2022 Aug 12. Epub 2022 Aug 12.

Department of Medicine, Stony Brook University, Stony Brook, NY, USA.

Background: Developmental ontogeny of neonatal thrombopoiesis retains characteristics that are distinct from adult although molecular mechanisms remain unestablished METHODS: We applied multiparameter quantitative platelet responses with integrated ribosome profiling/transcriptomic studies to better define gene/pathway perturbations regulating the neonatal-to-adult transition. A bioinformatics pipeline was developed to identify stable, neonatal-restricted platelet biomarkers for clinical application RESULTS: Cord blood (CB) platelets retained the capacity for linear agonist-receptor coupling linked to phosphatidylserine exposure (PS) and α-granule release, although a restricted block in cross-agonist activation pathways was evident. Functional immaturity of synergistic signaling pathways was due to younger ontogenetic age and singular underdevelopment of the protein secretory gene network, with reciprocal expansion of developmental pathways (E2F, G2M checkpoint, c-Myc) important for megakaryocytopoiesis. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Filter paper disks as a matrix for manipulation of recombinant proteins.

Authors:
Eric H Ball Nicoletta T Basilone

Anal Biochem 2022 Aug 9:114841. Epub 2022 Aug 9.

Department of Biochemistry, University of Western Ontario London, Ontario, N6G 3C3, Canada.

Filter paper provides an excellent matrix for retention of proteins containing a cellulose binding domain. To use this capability for manipulating recombinant fusion proteins, binding and elution parameters were explored and procedures developed for small scale purification, modification and assay. Proteins were tagged with the cellulose binding domain from the Clostridium thermocellum CipB gene via a cleavable linker. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Genomic mutation characteristics and prognosis of biliary tract cancer.

Authors:
Lingling Guo Fuping Zhou Huiying Liu Xiaoxia Kou Hongjuan Zhang Xiaofeng Chen Jinrong Qiu

Am J Transl Res 2022 15;14(7):4990-5002. Epub 2022 Jul 15.

Department of Biological Therapy, Eastern Hepatobiliary Surgery Hospital Shanghai 201805, China.

Background: The incidence of biliary system cancer is higher in the Chinese population than in the West. The overall prognosis of gallbladder cancer and cholangiocarcinoma is poor, and the current treatment is limited. In order to explore the pathogenesis of biliary tract cancers and potential targeted therapies, we mapped the mutation landscape of biliary tract cancer in the Chinese population and analyzed the molecular mechanism related to prognosis. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap